Amanda White
Physician Assistant · Arlington, TXNPI 1730452012
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $70,576 of the $87,939 with a category attached, or 80.3%. Medtronic accounts for 92.5% of it on its own, with 29 other manufacturers making up the rest. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 411 payments — averaging $213.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$81K
- Axonics, Inc.$1K
- Sumitomo Pharma America, Inc.$871
- Johnson & Johnson$841
- Astellas Pharma US Inc$376
- Boston Scientific$291
- plus $3K from 24 others
What the payments were for
- Consulting fees$4801%
- Speaking & faculty fees$70,57680%
- Travel & lodging$4,0365%
- Food & beverage$12,60914%
- Education$2390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 222 | $81,357 |
| Axonics, Inc. | 12 | $1,298 |
| Sumitomo Pharma America, Inc. | 63 | $871 |
| Johnson & Johnson | 14 | $841 |
| Astellas Pharma US Inc | 16 | $376 |
| Boston Scientific | 5 | $291 |
| Merck | 9 | $289 |
| Teleflex LLC | 2 | $262 |
| Myriad Genetic Laboratories, Inc. | 5 | $249 |
| AbbVie | 12 | $218 |
| Antares Pharma, Inc. | 2 | $212 |
| Procept Biorobotics Corporation | 2 | $208 |
| Bluewind Medical | 3 | $205 |
| Bayer | 6 | $184 |
| Ferring Pharmaceuticals Inc. | 3 | $159 |
| Avation Medical, Inc. | 2 | $136 |
| Myovant Sciences Inc. | 7 | $132 |
| Endo USA, Inc. | 1 | $130 |
| Dendreon Pharmaceuticals LLC | 6 | $129 |
| Blue Earth Diagnostics | 5 | $103 |
| Olympus America Inc. | 3 | $62 |
| Urogen Pharma, Inc. | 2 | $54 |
| Sanofi | 2 | $40 |
| Angiodynamics, Inc. | 1 | $29 |
| Valencia Technologies Corporation | 1 | $24 |
| Coloplast | 1 | $23 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $17 |
| Pfizer | 1 | $17 |
| Urovant Sciences Inc | 1 | $14 |
| Tolmar Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$87,939 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 504 | $370,672 |
| GemtesaVibegron | 218 | $169,764 |
| Mirabegron ErMirabegron | 56 | $29,065 |
| Methenamine Hippurate | 203 | $19,149 |
| Solifenacin Succinate | 285 | $13,926 |
| Trospium Chloride ErTrospium Chloride | 76 | $11,053 |
| PremarinEstrogens, Conjugated | 20 | $8,822 |
| Estradiol | 112 | $7,976 |
| Oxybutynin Chloride ErOxybutynin Chloride | 146 | $5,016 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 165 | $4,682 |
| NitrofurantoinNitrofurantoin Macrocrystal | 55 | $2,724 |
| Tolterodine Tartrate ErTolterodine Tartrate | 31 | $2,619 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 22 | $2,260 |
| Tamsulosin Hcl | 200 | $2,069 |
| Trospium Chloride | 20 | $1,903 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $376 | $370,672504 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $871 | $169,764218 claims |
| PfizerPremarin | $17 | $8,82220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Arlington
- Holly GloverArlington$418K
- Keith RegetsArlington$119K
- Lisa OstrowskiArlington$47K
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.